{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:18:47Z","timestamp":1783649927518,"version":"3.55.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T00:00:00Z","timestamp":1332979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recent studies have reported the presence of acetylcholine (ACh) receptor subtypes in bone tissue, and have demonstrated that inhibition of the ACh receptors has negative effects on bone mass and fracture healing capacity. However, little is known about the potential clinical effects that increased ACh signaling might have on bone. Accordingly, this study was designed to determine whether the use of acetylcholinesterase inhibitors (AChEIs), a group of drugs that stimulate ACh receptors and are used to treat Alzheimer's disease (AD), is associated with a decreased risk of hip fracture in AD patients. To accomplish this objective, a case-control analysis was performed using the AD population, aged above 75 years, based in the local health area of the Carlos Haya Hospital, in Malaga, Spain. The cases were 80 AD patients that suffered a hip fracture between January 2004 and December 2008. The controls were 2178 AD patients without hip fracture followed at our health care area during the same period of time. Compared with patients who did not use AChEIs, the hip fracture adjusted odds ratio (OR) for users of AChEIs was 0.42 (95% confidence interval [CI], 0.24\u20130.72), for users of rivastigmine was 0.22 (95% CI, 0.10\u20130.45), and for users of donepezil was 0.39 (95% CI, 0.19\u20130.76). Data were adjusted for the following parameters: body mass index, fall risk, smoking habits, cognition, dependence, degree of AD, comorbidity score, treatment with selective serotonin reuptake inhibitors, age, and gender. Our data suggests that use of AChEIs donepezil and rivastigmine is associated with a reduced risk of fractures in AD patients. Many elderly patients with AD disease who are at risk of developing osteoporosis may potentially benefit from therapy with the AChEIs donepezil and rivastigmine. \u00a9 2012 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.1616","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T11:24:49Z","timestamp":1333365889000},"page":"1518-1527","source":"Crossref","is-referenced-by-count":54,"title":["Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: A case-control study"],"prefix":"10.1093","volume":"27","author":[{"given":"Iskandar","family":"Tamimi","sequence":"first","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ojea","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Sanchez-Siles","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Facundo","family":"Rojas","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gormaz","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Perez","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Stefan","family":"Dawid-Milner","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Centro de Investigaciones M\u00e9dico-Sanitarias (CIMES), Universidad de Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mendez","sequence":"additional","affiliation":[{"name":"Traumatology and Orthopedic Surgery Department, Hospital Regional Universitario Carlos Haya, Malaga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faleh","family":"Tamimi","sequence":"additional","affiliation":[{"name":"Faculty of Dentistry, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,29]]},"reference":[{"issue":"6","key":"2024020318273432800_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S8756-3282(01)00427-6","article-title":"Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture","volume":"28","author":"Walker","year":"2001","journal-title":"Bone."},{"issue":"1","key":"2024020318273432800_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/scd.2008.0032","article-title":"Functional nicotinic and muscarinic receptors on mesenchymal stem cells","volume":"18","author":"Hoogduijn","year":"2009","journal-title":"Stem Cells Dev."},{"issue":"2","key":"2024020318273432800_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00441-009-0871-1","article-title":"Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis","volume":"338","author":"En-Nosse","year":"2009","journal-title":"Cell Tissue Res."},{"issue":"2","key":"2024020318273432800_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bone.2005.08.009","article-title":"Botox induced muscle paralysis rapidly degrades bone","volume":"38","author":"Warner","year":"2006","journal-title":"Bone."},{"key":"2024020318273432800_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1196\/annals.1402.009","article-title":"Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks","volume":"1116","author":"Grimston","year":"2007","journal-title":"Ann N Y Acad Sci."},{"issue":"13","key":"2024020318273432800_bib6","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/S0028-3908(00)00156-8","article-title":"Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus","volume":"39","author":"Alkondon","year":"2000","journal-title":"Neuropharmacology."},{"issue":"4","key":"2024020318273432800_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/(SICI)1097-4636(19990615)45:4<294::AID-JBM3>3.0.CO;2-1","article-title":"Impact of nicotine on bone healing","volume":"45","author":"Hollinger","year":"1999","journal-title":"J Biomed Mater Res."},{"issue":"2","key":"2024020318273432800_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijom.2007.08.001","article-title":"Nicotine impairs distraction osteogenesis in the rat mandible","volume":"37","author":"Glowacki","year":"2008","journal-title":"J Oral Maxillofacial Surg."},{"issue":"6","key":"2024020318273432800_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000242444","article-title":"High incidence of osteoporosis and fractures in an aging post-polio population","volume":"62","author":"Mohammad","year":"2009","journal-title":"Eur Neurol."},{"issue":"4","key":"2024020318273432800_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.febslet.2010.01.001","article-title":"Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts","volume":"584","author":"Sato","year":"2010","journal-title":"FEBS Lett."},{"issue":"4","key":"2024020318273432800_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(98)00187-2","article-title":"Osteoblast-derived acetylcholinesterase: a novel mediator of cell-matrix interactions in bone?","volume":"24","author":"Genever","year":"1999","journal-title":"Bone."},{"issue":"4","key":"2024020318273432800_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bone.2004.05.026","article-title":"Characterization of acetylcholinesterase expression and secretion during osteoblast differentiation","volume":"35","author":"Inkson","year":"2004","journal-title":"Bone."},{"issue":"2","key":"2024020318273432800_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/10731190902743149","article-title":"The influence of brain injury or peripheral nerve injury on calcitonin gene-related peptide concentration variation and fractures healing process","volume":"37","author":"Zhang","year":"2009","journal-title":"Artif Cells Blood Substit Immobil Biotechnol."},{"issue":"6","key":"2024020318273432800_bib14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/jbmr.19","article-title":"Uncoupled angiogenesis and osteogenesis in nicotine-compromised bone healing","volume":"25","author":"Ma","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318273432800_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/156720509787602861","article-title":"Cholinesterase inhibitors and beyond","volume":"6","author":"Pepeu","year":"2009","journal-title":"Curr Alzheimer Res."},{"issue":"1","key":"2024020318273432800_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/157015910790909520","article-title":"Update on the pharmacological treatment of Alzheimer's disease","volume":"8","author":"Massoud","year":"2010","journal-title":"Curr Neuropharmacol."},{"issue":"2","key":"2024020318273432800_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/pubmed\/fdh132","article-title":"Development and preliminary examination of the predictive validity of the Falls Risk Assessment Tool (FRAT) for use in primary care","volume":"26","author":"Nandy","year":"2004","journal-title":"J Public Health (Oxf)."},{"key":"2024020318273432800_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry."},{"key":"2024020318273432800_bib19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology."},{"key":"2024020318273432800_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental State\u201d: a practical method for grading the cognitive state patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res."},{"issue":"5","key":"2024020318273432800_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis."},{"issue":"6","key":"2024020318273432800_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1532-5415.1994.tb06859.x","article-title":"Fracture risk in patients with Alzheimer's disease","volume":"42","author":"Melton","year":"1994","journal-title":"J Am Geriatr Soc."},{"issue":"4","key":"2024020318273432800_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/ageing\/12.4.296","article-title":"Gait and balance in senile dementia of Alzheimer's type","volume":"12","author":"Visser","year":"1983","journal-title":"Age Ageing."},{"issue":"11","key":"2024020318273432800_bib24","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/jama.1987.03390110068028","article-title":"Falls and fractures in patients with Alzheimer-type dementia","volume":"257","author":"Buchner","year":"1987","journal-title":"JAMA."},{"issue":"1","key":"2024020318273432800_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0168-6054(00)00057-X","article-title":"Dementia and falls","volume":"44","author":"Strubel","year":"2001","journal-title":"Ann Readapt Med Phys."},{"issue":"3","key":"2024020318273432800_bib26","first-page":"189","article-title":"A population-based study on the association between dementia and hip fractures in 85-year olds","volume":"8","author":"Johanson","year":"1996","journal-title":"Aging (Milano)."},{"issue":"1","key":"2024020318273432800_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ageing\/afq146","article-title":"Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007","volume":"40","author":"Baker","year":"2011","journal-title":"Age Ageing."},{"issue":"2","key":"2024020318273432800_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2004.03.033","article-title":"Risk factors for hip fracture among elderly patients with Alzheimer's disease","volume":"223","author":"Sato","year":"2004","journal-title":"J Neurol Sci."},{"issue":"5","key":"2024020318273432800_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.annepidem.2003.08.005","article-title":"Hip fractures and Alzheimer's disease in elderly institutionalized Canadians","volume":"14","author":"Weller","year":"2004","journal-title":"Ann Epidemiol."},{"issue":"4","key":"2024020318273432800_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1532-5415.1995.tb05824.x","article-title":"Fracture risk in Alzheimer's disease patients","volume":"43","author":"Hussain","year":"1995","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"2024020318273432800_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ije\/29.2.253","article-title":"Tobacco smoking and risk of hip fracture in men and women","volume":"29","author":"H\u00f8idrup","year":"2000","journal-title":"Int J Epidemiol."},{"issue":"4","key":"2024020318273432800_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-2009-1185","article-title":"Bone density and brain atrophy in early Alzheimer's disease","volume":"18","author":"Loskutova","year":"2009","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"2024020318273432800_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-2010-1364","article-title":"Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's disease","volume":"20","author":"Loskutova","year":"2010","journal-title":"J Alzheimers Dis."},{"issue":"5","key":"2024020318273432800_bib34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","article-title":"Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline","volume":"148","author":"Raina","year":"2008","journal-title":"Ann Intern Med."},{"issue":"5\u20136","key":"2024020318273432800_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00228-005-0946-1","article-title":"A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"61","author":"Raschetti","year":"2005","journal-title":"Eur J Clin Pharmacol."},{"issue":"11","key":"2024020318273432800_bib36","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1532-5415.2009.02488.x","article-title":"Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the Veterans Affairs New England Healthcare System","volume":"57","author":"Hernandez","year":"2009","journal-title":"J Am Geriatr Soc."},{"issue":"10","key":"2024020318273432800_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ejcn.2009.35","article-title":"Body mass index is related to autonomic nervous system activity as measured by heart rate variability","volume":"63","author":"Molfino","year":"2009","journal-title":"Eur J Clin Nutr."},{"issue":"11","key":"2024020318273432800_bib38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ijo.2010.284","article-title":"Metabolic sequelae of \u03b2-blocker therapy: weighing in on the obesity epidemic?","volume":"35","author":"Lee","year":"2011","journal-title":"Int J Obes (Lond)."},{"issue":"2","key":"2024020318273432800_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12020-007-0021-z","article-title":"Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat","volume":"31","author":"Balbo","year":"2007","journal-title":"Endocrine."},{"issue":"5","key":"2024020318273432800_bib40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bone.2008.01.005","article-title":"Molecular bases of the sympathetic regulation of bone mass","volume":"42","author":"Takeda","year":"2008","journal-title":"Bone."},{"issue":"11","key":"2024020318273432800_bib41","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","article-title":"Use of beta-blockers and risk of fractures","volume":"292","author":"Schlienger","year":"2004","journal-title":"JAMA."},{"issue":"1","key":"2024020318273432800_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2010-101467","article-title":"Association between bone mineral density and the risk of Alzheimer's disease","volume":"24","author":"Zhou","year":"2011","journal-title":"J Alzheimers Dis."},{"key":"2024020318273432800_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0006-3223(00)00879-9","article-title":"Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's disease","volume":"48","author":"Pascualy","year":"2000","journal-title":"Biol Psychiatry."},{"key":"2024020318273432800_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-328X(00)00168-6","article-title":"Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease","volume":"84","author":"Szot","year":"2000","journal-title":"Brain Res Mol Brain Res."},{"issue":"6","key":"2024020318273432800_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1532-5415.2011.03450.x","article-title":"Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials","volume":"59","author":"Kim","year":"2011","journal-title":"J Am Geriatr Soc."},{"issue":"1","key":"2024020318273432800_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","article-title":"A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group","volume":"50","author":"Rogers","year":"1998","journal-title":"Neurology."},{"issue":"6","key":"2024020318273432800_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000017259","article-title":"Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group","volume":"11","author":"Homma","year":"2000","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"3","key":"2024020318273432800_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1212\/WNL.57.3.489","article-title":"A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","volume":"57","author":"Winblad","year":"2001","journal-title":"Neurology."},{"issue":"4","key":"2024020318273432800_bib49","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","article-title":"Donepezil in vascular dementia: a randomized, placebo-controlled study","volume":"61","author":"Wilkinson","year":"2003","journal-title":"Neurology."},{"issue":"9516","key":"2024020318273432800_bib50","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","article-title":"Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study","volume":"367","author":"Winblad","year":"2006","journal-title":"Lancet."},{"issue":"14","key":"2024020318273432800_bib51","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa066583","article-title":"Donepezil for the treatment of agitation in Alzheimer's disease","volume":"357","author":"Howard","year":"2007","journal-title":"N Engl J Med."},{"key":"2024020318273432800_bib52"},{"issue":"11","key":"2024020318273432800_bib53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/0003-4819-115-11-837","article-title":"Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group","volume":"115","author":"Seeley","year":"1991","journal-title":"Ann Intern Med."},{"issue":"12","key":"2024020318273432800_bib54","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/WNL.54.12.2261","article-title":"Galantamine in AD: a 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group","volume":"54","author":"Raskind","year":"2000","journal-title":"Neurology."},{"issue":"1\u20133","key":"2024020318273432800_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(00)00093-5","article-title":"Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease","volume":"393","author":"Maelicke","year":"2000","journal-title":"Eur J Pharmacol."},{"issue":"3","key":"2024020318273432800_bib56","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/jpet.102.045773","article-title":"Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors","volume":"305","author":"Samochocki","year":"2003","journal-title":"J Pharmacol Exp Ther."},{"issue":"2","key":"2024020318273432800_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2009-1058","article-title":"Acute but not chronic donepezil increases muscarinic receptor-mediated signaling via arachidonic acid in unanesthetized rats","volume":"17","author":"Basselin","year":"2009","journal-title":"J Alzheimers Dis."},{"issue":"3","key":"2024020318273432800_bib58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cmet.2010.01.005","article-title":"Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity","volume":"11","author":"Shi","year":"2010","journal-title":"Cell Metab."},{"issue":"1\u20132","key":"2024020318273432800_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-1838(95)00139-5","article-title":"The development of autonomic innervation in bone and joints of the rat","volume":"59","author":"Sisask","year":"1996","journal-title":"J Auton Nerv Syst."},{"issue":"6","key":"2024020318273432800_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000276591","article-title":"Development of rat tibia innervation: colocalization of autonomic nerve fiber markers with growth-associated protein 43","volume":"191","author":"Gajda","year":"2010","journal-title":"Cells Tissues Organs."},{"issue":"11","key":"2024020318273432800_bib61","first-page":"1426","article-title":"Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date","volume":"166","author":"Hodsman","year":"2002","journal-title":"CMAJ."},{"issue":"4","key":"2024020318273432800_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semarthrit.2010.06.001","article-title":"The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis","volume":"40","author":"Jansen","year":"2011","journal-title":"Semin Arthritis Rheum."},{"issue":"19","key":"2024020318273432800_bib63","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med."},{"issue":"3","key":"2024020318273432800_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1185\/030079902125000471","article-title":"Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil","volume":"18","author":"Auriacombe","year":"2002","journal-title":"Curr Med Res Opin."},{"issue":"3","key":"2024020318273432800_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/gps.2487","article-title":"Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability","volume":"26","author":"Kinnair","year":"2011","journal-title":"Int J Geriatr Psychiatry."},{"issue":"4","key":"2024020318273432800_bib66","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1532-5415.2010.02767.x","article-title":"Competing risk of death: an important consideration in studies of older adults","volume":"58","author":"Berry","year":"2010","journal-title":"J Am Geriatr Soc."},{"issue":"7","key":"2024020318273432800_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","article-title":"Survival after initial diagnosis of Alzheimer disease","volume":"140","author":"Larson","year":"2004","journal-title":"Ann Intern Med."},{"key":"2024020318273432800_bib68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-244X-11-190","article-title":"Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia","volume":"11","author":"Hoffmann","year":"2011","journal-title":"BMC Psychiatry."},{"issue":"3","key":"2024020318273432800_bib69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/JGP.0b013e3181e56d30","article-title":"Cholinesterase inhibitors for Alzheimer disease: do they provide more than symptomatic benefits?","volume":"19","author":"Suh","year":"2011","journal-title":"Am J Geriatr Psychiatry."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1616","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/7\/1518\/56561461\/1616_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/7\/1518\/56561461\/1616_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:46:32Z","timestamp":1710341192000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/7\/1518-1527\/7598418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,29]]},"references-count":69,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,3,29]]},"published-print":{"date-parts":[[2012,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1616","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,7,1]]},"published":{"date-parts":[[2012,3,29]]}}}